The pledge was signed by the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi.
The drugmakers promised to prioritize vaccine safety, conduct clinical trials scientifically and ethically, pursue a range of vaccine offerings and only submit treatments for FDA approval after they have maintained safety and efficacy through phase 3 testing.
“We believe this pledge will help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved,” the drugmakers wrote.
Read the full pledge here.
More articles on pharmacy:
5 requests biotech CEOs have for their peers, the FDA regarding COVID-19 vaccine development
CDC sends plans to states for COVID-19 vaccine distribution by early November
Operation Warp Speed head: ‘I would immediately resign if there is undue interference’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
